Jinnan Chen

Sep 22, 2024 | onlinelibrary.wiley.com | Yu Huang |Shuhan Qiu |Yixian Guo |Jinnan Chen

Background The optimal dosage of minocycline remains unclear for Helicobacter pylori (H. pylori) eradication. We aimed to evaluate the efficacy and safety of four different regimens with minocycline and metronidazole compared to classical bismuth quadruple therapy for H. pylori rescue treatment. Materials and Methods From March 2021 to March 2024, refractory H.

Aug 1, 2024 | onlinelibrary.wiley.com | Shuhan Qiu |Yu Huang |Jinnan Chen |Yixian Guo

Conflicts of Interest Hong Lu has served as a paid speaker for CMS group, Hanhui-pharma, Headway, Abbott, AstraZeneca, and Takeda. All other authors have no conflicts of interest to declare. Supporting Information Filename Description hel13118-sup-0001-TableS1.docxWord 2007 document , 18.6 KB Table S1. hel13118-sup-0002-TableS2.docxWord 2007 document , 19.3 KB Table S2.

Feb 12, 2024 | thelancet.com | Jinnan Chen |Hong Lu

• None Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. :• None Design, synthesis, and characterization of TNP-2198, a dual-targeted rifamycin-nitroimidazole conjugate with potent activity against microaerophilic and anaerobic bacterial pathogens.